These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32653835)

  • 21. Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study.
    Li Z; Herold T; He C; Valk PJ; Chen P; Jurinovic V; Mansmann U; Radmacher MD; Maharry KS; Sun M; Yang X; Huang H; Jiang X; Sauerland MC; Büchner T; Hiddemann W; Elkahloun A; Neilly MB; Zhang Y; Larson RA; Le Beau MM; Caligiuri MA; Döhner K; Bullinger L; Liu PP; Delwel R; Marcucci G; Lowenberg B; Bloomfield CD; Rowley JD; Bohlander SK; Chen J
    J Clin Oncol; 2013 Mar; 31(9):1172-81. PubMed ID: 23382473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a promising 5-gene prognostic model for pediatric acute myeloid leukemia.
    Tao Y; Wei L; Shiba N; Tomizawa D; Hayashi Y; Ogawa S; Chen L; You H
    Mol Biomed; 2024 Jan; 5(1):1. PubMed ID: 38163849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of distinctive long noncoding RNA competitive interactions and a six-methylated-gene prognostic signature in acute myeloid leukemia with -5/del(5q) or -7/del(7q).
    Yin X; Huang S; Xu A; Fan F; Chen L; Sun C; Hu Y
    J Cell Biochem; 2020 Feb; 121(2):1563-1574. PubMed ID: 31535409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic Analysis of Autophagy-Related Signature Uncovers Prognostic Predictor for Acute Myeloid Leukemia.
    Chen XX; Li ZP; Zhu JH; Xia HT; Zhou H
    DNA Cell Biol; 2020 Sep; 39(9):1595-1605. PubMed ID: 32783661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification.
    van der Werf I; Wojtuszkiewicz A; Meggendorfer M; Hutter S; Baer C; Heymans M; Valk PJM; Kern W; Haferlach C; Janssen JJWM; Ossenkoppele GJ; Cloos J; Haferlach T
    Blood Adv; 2021 Sep; 5(17):3254-3265. PubMed ID: 34448812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.
    Díaz-Beyá M; Brunet S; Nomdedéu J; Cordeiro A; Tormo M; Escoda L; Ribera JM; Arnan M; Heras I; Gallardo D; Bargay J; Queipo de Llano MP; Salamero O; Martí JM; Sampol A; Pedro C; Hoyos M; Pratcorona M; Castellano JJ; Nomdedeu M; Risueño RM; Sierra J; Monzó M; Navarro A; Esteve J
    Blood Cancer J; 2015 Oct; 5(10):e352. PubMed ID: 26430723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Wang WD
    Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia.
    Cheng H; Huang C; Xu X; Hu X; Gong S; Tang G; Song X; Zhang W; Wang J; Chen L; Yang J
    J Transl Med; 2017 Aug; 15(1):179. PubMed ID: 28851457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia.
    Wang J; Hao JP; Uddin MN; Wu Y; Chen R; Li DF; Xiong DQ; Ding N; Yang JH; Ding XS
    Aging (Albany NY); 2021 Jun; 13(12):16445-16470. PubMed ID: 34148032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
    Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A three-gene signature might predict prognosis in patients with acute myeloid leukemia.
    Zhu X; Zhao Q; Su X; Ke J; Yi Y; Yi J; Lin J; Qian J; Deng Z
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32436945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.
    Wan Q; Sang X; Jin L; Wang Z
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma.
    Shi Y; Chen Z; Gao J; Wu S; Gao H; Feng G
    Oncol Rep; 2018 Oct; 40(4):2014-2022. PubMed ID: 30106437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia.
    Masetti R; Togni M; Astolfi A; Pigazzi M; Manara E; Indio V; Rizzari C; Rutella S; Basso G; Pession A; Locatelli F
    Oncotarget; 2013 Oct; 4(10):1712-20. PubMed ID: 24127550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients.
    Marcel V; Catez F; Berger CM; Perrial E; Plesa A; Thomas X; Mattei E; Hayette S; Saintigny P; Bouvet P; Diaz JJ; Dumontet C
    PLoS One; 2017; 12(1):e0170160. PubMed ID: 28103300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A CD8
    Li Z; Jin P; Xiang R; Li X; Shen J; He M; Liu X; Zhu H; Wu S; Dong F; Zhao H; Liu H; Jin Z; Li J
    Front Immunol; 2024; 15():1408109. PubMed ID: 39346926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system.
    Röllig C; Bornhäuser M; Thiede C; Taube F; Kramer M; Mohr B; Aulitzky W; Bodenstein H; Tischler HJ; Stuhlmann R; Schuler U; Stölzel F; von Bonin M; Wandt H; Schäfer-Eckart K; Schaich M; Ehninger G
    J Clin Oncol; 2011 Jul; 29(20):2758-65. PubMed ID: 21632498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia.
    Wang E; Lu SX; Pastore A; Chen X; Imig J; Chun-Wei Lee S; Hockemeyer K; Ghebrechristos YE; Yoshimi A; Inoue D; Ki M; Cho H; Bitner L; Kloetgen A; Lin KT; Uehara T; Owa T; Tibes R; Krainer AR; Abdel-Wahab O; Aifantis I
    Cancer Cell; 2019 Mar; 35(3):369-384.e7. PubMed ID: 30799057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data.
    Xu N; Ke ZB; Lin XD; Lin F; Chen SH; Wu YP; Chen YH; Wei Y; Zheng QS
    Aging (Albany NY); 2020 Mar; 12(6):4996-5009. PubMed ID: 32217810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia.
    Shi L; Huang R; Lai Y
    BMC Med Genomics; 2021 May; 14(1):127. PubMed ID: 33985510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.